# Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia

> **NCT05129254** · NA · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DEVICE:** Fractionated Thulium laser
- **PROCEDURE:** Autologous Platelet Rich Plasma Injection
- **PROCEDURE:** Autologous Platelet Rich Plasma Topical Application

## Key facts

- **NCT ID:** NCT05129254
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study not initiated.
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129254, "Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05129254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*